Medical technology firm Heartflow said on Thursday it had raised $316.7 million in its U.S. initial public offering, setting the stage for its Nasdaq debut in another test of investor appetite for ...

Heartflow, backed by private investment firm Bain Capital, said on Wednesday it was targeting a valuation of up to $1.46 ...

Heartflow has priced its previously announced initial public offering (IPO), with proceeds potentially reaching up to $300 ...

Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), a leader in AI technology for coronary artery disease (CAD), today announced the pricing of its upsized initial public offering of 16,666,667 shares of its ...

It seems there’s fresh blood pumping back into the IPO market. After a blowout initial public offering from Figma last week, ...

HeartFlow joins a group of medtechs planning to go public in 2025, including Medtronic’s new standalone diabetes business and ...

The company, which sells software for creating 3D heart models, plans to offer 12.5 million shares at a range of $15 to $17 ...

Heartflow has pumped up its IPO ambitions, raising its proposal into the vicinity of $300 million. | After first pricing its ...

Heartflow on Wednesday said it now plans to sell nearly 16.7 million shares at between $17 and $18 apiece in the IPO, compared with prior plans to offer 12.5 million shares at between $15 and $17 each ...

Heartflow said it would have about 79.5 million shares outstanding after the IPO, assuming an exercise of the overallotment option, for a market capitalization topping $1.27 billion at the $16-a-share ...

Like waves crashing on the beach, med-tech IPOs keep on coming. Heartflow Inc. set terms for its IPO on Aug. 1, offering 12.5 ...

Medical technology firm Heartflow said on Thursday it has raised $316.7 million in its U.S. initial public offering.